Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Treasury Shares (2020 - 2025)

Historic Treasury Shares for Tango Therapeutics (TNGX) over the last 4 years, with Q3 2025 value amounting to $1.3 million.

  • Tango Therapeutics' Treasury Shares rose 655.28% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 655.28%. This contributed to the annual value of $1.2 million for FY2024, which is 5964.5% up from last year.
  • As of Q3 2025, Tango Therapeutics' Treasury Shares stood at $1.3 million, which was up 655.28% from $1.4 million recorded in Q2 2025.
  • Over the past 5 years, Tango Therapeutics' Treasury Shares peaked at $1.5 million during Q1 2025, and registered a low of $633626.0 during Q1 2023.
  • In the last 3 years, Tango Therapeutics' Treasury Shares had a median value of $1.2 million in 2024 and averaged $1.1 million.
  • Per our database at Business Quant, Tango Therapeutics' Treasury Shares soared by 9798.05% in 2024 and then surged by 655.28% in 2025.
  • Over the past 3 years, Tango Therapeutics' Treasury Shares (Quarter) stood at $757514.0 in 2023, then surged by 59.64% to $1.2 million in 2024, then rose by 5.66% to $1.3 million in 2025.
  • Its Treasury Shares was $1.3 million in Q3 2025, compared to $1.4 million in Q2 2025 and $1.5 million in Q1 2025.